Mpa2l Inhibitors
Chemical inhibitors of Mpa2l target various signaling pathways to modulate the activity of this protein. Staurosporine, a broad-spectrum protein kinase inhibitor, can disrupt the phosphorylation process essential for Mpa2l's function, thus hindering its activity. LY294002 and Wortmannin, both PI3K inhibitors, can prevent the activation of the Akt pathway, leading to reduced Mpa2l activity by blocking necessary downstream signaling. Similarly, PD98059 and U0126, which inhibit MEK1/2 in the MAPK/ERK pathway, can decrease Mpa2l's activity by obstructing the signaling routes critical for its function. SP600125 and SB203580 specifically target JNK and p38 MAP kinase within the MAPK pathway, respectively, and can inhibit Mpa2l by preventing the propagation of signals necessary for its activity.
Further, Rapamycin, an mTOR inhibitor, can inhibit Mpa2l by halting the mTOR signaling pathways it relies on. Y-27632, which inhibits ROCK kinase, can disrupt the Rho/ROCK pathway signaling processes that regulate Mpa2l activity. PP2, as an inhibitor of Src family tyrosine kinases, can impede the kinase activity necessary for the function of Mpa2l. ZM-447439, an Aurora kinase inhibitor, can inhibit Mpa2l by disrupting the Aurora kinase-dependent pathways crucial for its function. Lastly, Bortezomib, by its action as a proteasome inhibitor, can block the ubiquitin-proteasome system-dependent degradation signals that Mpa2l relies on for its regulation, thereby inhibiting its functional activity.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases. Mpa2l, being a part of specific signaling pathways that rely on phosphorylation, can be inhibited by staurosporine due to its ability to prevent the phosphorylation process essential for Mpa2l function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a specific inhibitor of PI3K, an enzyme involved in the Akt pathway. Mpa2l, whose activity is regulated by the Akt pathway, can be inhibited by LY294002 as it prevents the downstream signaling required for Mpa2l to function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, which is part of the MAPK/ERK pathway. Mpa2l function is dependent on this pathway, and inhibition by PD98059 can lead to a decrease in Mpa2l's activity as it disrupts the pathway's signaling. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, a kinase within the MAPK pathway. Mpa2l activity can be inhibited by SP600125 due to the prevention of JNK's role in signaling cascades that regulate Mpa2l function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a selective inhibitor of p38 MAP kinase. Mpa2l relies on the p38 MAPK pathway for its function, and SB203580 can inhibit Mpa2l by hindering the pathway's ability to propagate signals necessary for Mpa2l activity. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a selective inhibitor of MEK1/2, key components of the ERK pathway. As Mpa2l's activity is modulated by the ERK pathway, inhibition by U0126 leads to reduced functional activity of Mpa2l by blocking this essential signaling route. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent inhibitor of PI3K. As the PI3K/Akt pathway influences Mpa2l activity, inhibition by wortmannin can decrease Mpa2l activity by disrupting the signaling required for its function. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a key regulator of cell growth and proliferation. Mpa2l, being regulated by pathways involving mTOR, can be functionally inhibited by rapamycin, which blocks the signaling necessary for Mpa2l activity. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is an inhibitor of ROCK kinase. Mpa2l function that relies on the Rho/ROCK pathway can be inhibited by Y-27632, as it disrupts the signaling processes that regulate Mpa2l activity. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an inhibitor of Src family tyrosine kinases. Mpa2l, whose function can be influenced by Src-mediated signaling, can be inhibited by PP2, which impedes the kinase activity necessary for Mpa2l function. | ||||||